MAPK14 and cancer: The reverse signaling enables transendothelial migration of cancer cells via dissolution of adherens junctions through p38-increased actin contractility and opening of IEJs and but also via physical defect of the endothelial barrier as a consequence of endothelial cell necroptosis.